Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The in-vitro and animal data suggest that TRG-100 can safely be used for possible intravesical sustained release of Lidocaine and Oxybutynin in the treatment of BPS/IC.
Lead Product(s): Oxybutynin,Lidocaine
Therapeutic Area: Urology Product Name: TRG-100
Highest Development Status: PreclinicalProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable July 22, 2021